¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Longitudinal reduction defect of radius"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • medial longitudinal fasciculus
    ¾ÈÂʼ¼·Î´Ù¹ß, ³»ÃøÁ¾¼Ó
  • superior longitudinal fasciculus
    À§¼¼·Î´Ù¹ß, »óÁ¾¼Ó
  • associated defect
    ¿¬°üÀå¾Ö
  • atrial septal defect
    ½É¹æ»çÀ̸·°á¼Õ, ½É¹æÁ߰ݰá¼Õ
  • atrioventricular canal defect
    ¹æ½Ç°ü°á¼Õ(Áõ)
  • atrioventricular septal defect
    ¹æ½Ç»çÀ̸·°á¼Õ(Áõ), ¹æ½ÇÁ߰ݰá¼Õ(Áõ)
  • auditory defect
    û°¢°á¼Õ
  • abdominal wall defect
    ¹èº®°á¼Õ, º¹º®°á¼Õ
  • afferent pupillary defect
    µé½Å°æµ¿°ø°á¼Õ, ±¸½É½Å°æµ¿°ø°á¼Õ
  • altitudinal visual field defect
    ¼öÆò½Ã¾ß°á¼Õ
  • color vision defect
    »ö°¢°áÇÔ
  • composition defect
    ±¸¼º°áÇÔ
  • conduction defect
    ÀüµµÀå¾Ö
  • congenital defect
    ¼±Ãµ°áÇÔ, ¼±Ãµ°á¼Õ(Áõ)
  • congruous field defect
    ÀÏÄ¡½Ã¾ß°á¼Õ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • longitudinal scan
    ¼¼·ÎÃེĵ, Á¾Ãེĵ
  • longitudinal section
    ¼¼·Î´Ü¸é
  • longitudinal study
    ÃßÀû¿¬±¸
  • abdominal wall defect
    ¹èº®°á¼Õ
  • aggregation defect
    ÀÀÁý°áÇÔ
  • altitudinal visual field defect
    ¼öÆò½Ã¾ß°á¼Õ
  • associated defect
    ¿¬ÇÕ°áÇÔ, ¿¬ÇÕ°á¼Õ, ¼ö¹ÝÀå¾Ö
  • atrial septal defect
    ½É¹æ»çÀ̸·°á¼Õ, ½É¹æÁ߰ݰá¼Õ
  • atrioventricular canal defect
    ¹æ½Ç°ü°á¼Õ(Áõ)
  • atrioventricular septal defect
    ¹æ½Ç»çÀ̸·°á¼Õ(Áõ), ¹æ½ÇÁ߰ݰá¼Õ(Áõ)
  • auditory defect
    û°¢°á¼Õ
  • biochemical defect syndrome
    »ýÈ­ÇÐÀû°áÇÔÁõÈıº
  • canalization defect
    °üÇü¼º°áÇÔ
  • color vision defect
    »ö°¢°áÇÔ
  • composition defect
    ±¸¼º°áÇÔ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • reduction potential
    ȯ¿øÀüÀ§.
  • reduction rhinoplasty
    Ãà¼Òºñ¼ºÇü¼ú
  • reduction semiconductor
    ȯ¿øÇü¹ÝµµÃ¼(ü½êªû¡ÚâÓôô÷).
  • reduction test
    ȯ¿ø½ÃÇè.
  • ECD=£¾endocardial cushion defect
    ½É³»¸·»ó°á¼Õ(Áõ).
  • Interventricular septal defect
    ½É½ÇÁ߰ݰá¼ÕÁõ(ãýãøñḛ́ÌÀáßñø)
  • VSD= ventricular septal defect
    ½É½ÇÁ߰ݰá¼Õ.
  • acquired color vision defect
    ÈÄõ»ö°¢ÀÌ»ó
  • afferent pupillary defect
    ±¸½É¼ºµ¿°ø¿îµ¿Àå¾Ö
  • altitudinal visual field defect
    ¼öÆò½Ã¾ß°á¼Õ
  • amniotic defect
    ¾ç¸·°áÇÔ
  • aortic septal defect
    ´ëµ¿¸ÆÁ߰ݰá¼Õ(ÓÞÔÑØæñḛ́ÌÀáß).
  • aortic septal defect
    ´ëµ¿¸ÆÁ߰ݰá¼Õ(ÓÞÔÑØæñḛ́ÌÀáß).
  • aorticopulmonary septal defect
    ´ëµ¿¸ÆÆóµ¿¸ÆÁ߰ݰá¼Õ(¡­ñḛ́ÌÀáß).
  • aorticopulmonary septal defect
    ´ëµ¿¸ÆÆóµ¿¸ÆÁ߰ݰá¼Õ(¡­ñḛ́ÌÀáß).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • proportional reduction
    ºñ·Ê°¨·Â(ÝïçÓÊõæ³).
  • reduction
    Á¤º¹¼ú, °¨¼Ò, Ãà¼Ò
  • reduction
    Á¤º¹, °¨¼Ò
  • reduction
    ȯ¿ø(ü½êª), °¨¼Ò.
  • reduction discharge
    ȯ¿ø¼º¹æ.
  • reduction division
    °¨¼öºÐ¿­
  • reduction division
    °¨¼öºÐ¿­(Êõâ¦ÝÂæñ).
  • reduction division
    °¨¼öºÐ¿­
  • reduction in area
    ´Ü¸é¼öÃà·ü(Ó¨Øüâ¥õêëÒ).
  • reduction of cardiac work load
    ½ÉÀÛ¾÷·®ÀÇ °æ°¨(ãýíÂåöåÖ¡­ÌîÊõ).
  • reduction of chromosome
    ¿°»öü°¨¼ö(æøßäô÷Êõâ¦).
  • reduction of fraction
    ¾àºÐ(å³ÝÂ).
  • reduction of fracture
    °ñÀý Á¤º¹(Íéï¹ïÚÜÖ).
  • reduction potential
    ȯ¿øÀüÀ§.
  • reduction rhinoplasty
    Ãà¼Òºñ¼ºÇü¼ú
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • Defect of brain
    ³ú°áÇÔ
    [¿¾ ¿ë¾î] ³ú°áÇÔ
  • Perforation defect
    ¶Õ¸²°áÇÔ
    [¿¾ ¿ë¾î] õ°ø°áÇÔ
  • Defect of membranous part
    ¸·ºÎºÐ°áÇÔ
    [¿¾ ¿ë¾î] ¸·¼ººÎ°áÇÔ
  • Defect of Head
    ¸Ó¸®°áÇÔ
    [¿¾ ¿ë¾î] µÎºÎ°áÇÔ
  • Cranial defect
    ¸Ó¸®»À°áÇÔ
    [¿¾ ¿ë¾î] µÎ°³°ñ°áÇÔ
  • Metabolic defect of minerals (Asiderosis)
    ¹«±âÁú´ë»ç°áÇÔ(ö°¨¼ÒÁõ)
    [¿¾ ¿ë¾î] ¹«±âÁú´ë»ç°áÇÔ(ö°¨¼ÒÁõ)
  • Defect of Abdomen
    ¹è°áÇÔ
    [¿¾ ¿ë¾î] º¹ºÎ°áÇÔ
  • Subtotal heart defect
    ºÎºÐ½ÉÀå°áÇÔ
    [¿¾ ¿ë¾î] ½ÉÀåºÎºÐ°áÇÔ
  • Separation defect
    ºÐ¸®°áÇÔ
    [¿¾ ¿ë¾î] ºÐ¸®°áÇÔ
  • Separation defect (Syndactylia)
    ºÐ¸®°áÇÔ (¼Õ°¡¶ôÀ¶ÇÕÁõ)
    [¿¾ ¿ë¾î] ºÐ¸®°áÇÔ (¼Õ°¡¶ôÀ¶ÇÕÁõ)
  • Cleavage defect
    ºÐÇÒ°áÇÔ
    [¿¾ ¿ë¾î] ³­ÇÒ°áÇÔ
  • Differentiation defect
    ºÐÈ­°áÇÔ
    [¿¾ ¿ë¾î] ºÐÈ­°áÇÔ
  • Defect of urogenital organ
    ºñ´¢»ý½Ä±â°ü°áÇÔ
    [¿¾ ¿ë¾î] ºñ´¢»ý½Ä±â°ü°áÇÔ
  • Defect of Skeleton
    »À´ë°áÇÔ
    [¿¾ ¿ë¾î] °ñ°Ý°áÇÔ
  • Septation defect
    »çÀ̸·Çü¼º°áÇÔ
    [¿¾ ¿ë¾î] Áß°ÝÇü¼º°áÇÔ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
long longitudinal
LPC late positive component; lipocortin; longitudinal primary care [program]; lysophosphatidylcholine
LS lateral suspensor; left sacrum; left septum; left side; legally separated; leiomyosarcoma; length of...
L/S lactase/sucrase [ratio]; lecithin/ sphingomyelin [ratio]; lipid/saccharide [ratio]; longitudinal sec...
LSect longitudinal section
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
ONTD open neural tube defect
VFD visual field defect
ARR Absolute risk reduction
ALSPAC Avon Longitudinal Study of Pregnancy and Childhood
BLSA Baltimore Longitudinal Study of Aging
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • morphologic defect
    ÇüÅ °áÇÔ
  • ostium primum atrial septal defect
    ÀÏÂ÷ °øÇü ½É¹æ Áß°Ý °á¼Õ
  • paraplacental chorionic defect
    ÅÂ¹Ý °ç À¶¸ð¸· °áÇÔ
  • perceptual defect
    Áö°¢ °á¼Õ
  • peroxidase defect
    °ú»êÈ­È¿¼Ò °á¼Õ
  • punch out defect
    ±¸¸Û °á¼Õ
  • qualitative platelet defect
    Á¤»ó Ç÷¼ÒÆÇ °áÇÌÁõ, ÁúÀû Ç÷¼ÒÆÇ °áÇÔ
  • quantum defect
    ¾çÀÚ °á¼Õ
  • skeletal defect
    °ñ°Ý °á¼Õ
  • small atrial septal defect
    ¹Ì¼¼ ½É¹æ Áß°Ý °á¼Õ
  • substance defect
    ¹°Áú °áÇÌ
  • superficial defect
    Ç¥À缺 °á¼Õ
  • ventricular septal defect
    ½É½Ç Áß°Ý °á¼Õ
    ¼±Ãµ¼º ½ÉÁúȯ¿¡¼­ ºóµµ°¡ ³ôÀº °ÍÀÇ ÇϳªÀÌ´Ù. ½É½Ç Áß°Ý¿¡ °á¼ÕÀÌ ÀÖ´Â °ÍÀ» ¸»ÇÑ´Ù. º¸Åë ½É½Ç Áß°Ý ¸·¼º ºÎÀ§ÀÇ °á¼ÕÀε¥ ±Ù¼º ºÎÀ§¿¡ °á¼ÕÀÌ ÀÖ´Â °Íµµ ÀÖ´Ù. °á¼Õ°øÀÇ Å©±â´Â ´Ù¾çÇÏ´Ù. ÀϹÝÀûÀ¸·Î ¿¹ÈÄ´Â ¾çÈ£Çϰí ÀÚ¿¬ Æó¼âµµ ÀÖ´Ù. Ä¡·á´Â ¿Ü°úÀûÀ¸·Î Æó¼â¸¦ ÇÑ´Ù.
  • visual field defect
    ½Ã¾ß °á¼Õ
    ¸Á¸·¿¡¼­ ´ë³ú ÇÇÁú¿¡ À̸£´Â ½Ã°¢°èÀÇ Àå¾Ö·Î ÀÎÇÑ ½Ã¾ßÀÇ ÀÌ»ó.
  • wedge shape defect
    ¼³»ó °á¼Õ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
oxidation-reduction A chemical reaction in which an electron is transferred from one molecule to another. The electron-donating molecule is the reducing agent or reductant; the electron-accepting molecule is the oxidizing agent or oxidant. Reducing and oxidizing agents function as conjugate reductant-oxidant pairs or redox pairs.
(12 Dec 1998)
oxidation-reduction electrode An electrode capable of measuring oxidation-reduction potential.
See: quinhydrone electrode.
Synonym: redox electrode.
(05 Mar 2000)
oxidation-reduction indicator A substance that undergoes a definite colour change at a specific oxidation potential.
Synonym: redox indicator.
(05 Mar 2000)
oxidation-reduction potential <chemistry, physics> The potential in volts of an inert metallic electrode measured in a system of an arbitrarily chosen ratio of [oxidant] to [reductant] and referred to the normal hydrogen electrode at absolute temperature.
It is calculated from the following equation: where R is the gas constant expressed in electrical units, T the absolute temperature (Kelvin), n the number of electrons transferred, F the faraday and E0 the normal symbol for the potential of the system at pH 0; for biological systems E0' is often used (in which pH = 7).
Compare: Nernst's equation.
Synonym: redox potential.
(05 Mar 2000)
oxidation-reduction reaction <chemistry> Any reaction in which electrons are removed from one molecule or atom and given to another molecule or atom.
(09 Oct 1997)
oxidation-reduction system <enzyme> An enzyme system in the tissues by which oxidation and reduction proceed simultaneously through the transference of hydrogen or of one or more electrons from one metabolite to another.
See: oxidation-reduction.
Synonym: redox system.
(05 Mar 2000)
tuberosity reduction The surgical excision of excessive fibrous or bony tissue in the area of the maxillary tuberosity prior to the construction of prosthetic appliances.
(05 Mar 2000)
acquired platelet function defect <haematology> Platelet function can be affected by a number of different disease processes including polycythaemia vera, leukaemia, myelofibrosis, renal failure, multiple myeloma and some medications (for example penicillins, salicylates, phenothiazines).
Disturbed blood clotting can be manifested by: easy bruising, bleeding gums, nosebleeds, abnormal vaginal bleeding, rectal bleeding, skin rash, vomiting blood, coughing up blood or blood in the urine. A measure of bleeding time and coagulation profile will be part of the evaluation.
(29 Dec 1997)
aortic septal defect A small congenital opening between the aorta and pulmonary artery about 1 cm above the semilunar valves, e.g., aorticopulmonary window.
Synonym: aorticopulmonary window.
(05 Mar 2000)
aortopulmonary septal defect A congenital anomaly in which there is abnormal communication between the ascending aorta and pulmonary artery just above the semilunar valves.
(12 Dec 1998)
atrial septal defect <cardiology> An inherited condition where there is nonclosure of the foramen ovale at birth, resulting in congenital heart disease. Usually asymptomatic until the third or fourth decades of life.
Symptoms include exertional shortness of breath, fatigue and palpitations.
Acronym: ASD
(12 Jan 1998)
atrial ventricular canal defect A defect caused by deficient or absent septal tissue immediately above and below the normal level of the atrioventricular valves, including the region normally occupied by the A-V septum in hearts with two ventricles. The A-V valves are abnormal to a varying degree.
(05 Mar 2000)
birth defect Defect present at birth; sometimes referred to as congenital defect.
(05 Mar 2000)
ventricular septal defect <cardiology, embryology> A congenital heart defect where an abnormal opening exists in the ventricular septum. Blood flows from the higher pressure left ventricle (through the defect) into the right ventricle.
(12 Jan 1998)
Gerbode defect <cardiology, embryology> A defect in the interventricular portion of the membranous septum, associated with a communication between the right ventricle and the right atrium through an abnormality in the tricuspid valve.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á